Several lines of functional evidence have supported a role for the TGF-β superfamily in mediating aspirin/NSAIDs protective effects against CRC [32], particularly in models of mismatch repair deficient CRC [33]. This evidence concerns the gene TGFB1 and colorectal carcinoma.